This story has been updated to include comments from the company's earnings call.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the first quarter were up 7 percent year over year, with the company showing broad-based growth across the range of its customers, product lines, and geographies.

The company posted revenues of $460.4 million for the three months ended April 4, compared to $430.5 million in Q1 2014, beating the average Wall Street estimate of $445.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.